Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/121563
Title: COVALENT DRUG BINDING: A MECHANISTIC EXPLORATION TO ENHANCE SAFETY AND EFFICACY
Authors: CHAN CHUN YIP
Keywords: Covalent drug binding, acetaminophen, glutathionylation, lapatinib, endoxifen, mechanism-based inactivation
Issue Date: 12-Aug-2015
Citation: CHAN CHUN YIP (2015-08-12). COVALENT DRUG BINDING: A MECHANISTIC EXPLORATION TO ENHANCE SAFETY AND EFFICACY. ScholarBank@NUS Repository.
Abstract: COVALENT DRUG BINDING TO PROTEINS RESULTS IN DELETERIOUS EFFECTS. ADVERSE DRUG REACTIONS OCCUR WHEN OVERT COVALENT BINDING ALTERS PROTEIN STRUCTURE AND FUNCTION DIRECTLY, OR INDIRECTLY, BY COVERTLY INDUCING ABERRANT PROTEIN POST-TRANSLATIONAL MODIFICATIONS SUCH AS PROTEIN GLUTATHIONYLATION. USING ACETAMINOPHEN (APAP) AS A MODEL TOXICANT, WE UNCOVERED A SUITE OF PROTEINS GLUTATHIONYLATED BY APAP, AND CORRELATED THEM TO SIGNATURES OF APAP HEPATOTOXICITY USING PROTEO-METABONOMIC MAPPING. BASED ON THE MAPPING, WE FURTHER ELUCIDATED THE MECHANISMS OF ACTION OF PROPHYLACTICS AND ANTIDOTES AGAINST APAP HEPATOTOXICITY. OVERT COVALENT BINDING CAN LEAD TO INACTIVATION OF CYP450 ENZYMES AND CAUSE DRUG-DRUG INTERACTIONS (DDIS). WE EXPLORED DRUG DEUTERATION TO REDUCE REACTIVE METABOLITE FORMATION AND PATIENT GENOTYPING TO STRATIFY SUSCEPTIBILITY TO DDIS CAUSED BY LAPATINIB. WE NEGATED THE APPARENT LIABILITY OF COVALENT BINDING BY INVESTIGATING THE INTERACTION BETWEEN LAPATINIB AND ENDOXIFEN, REVEAL
URI: http://scholarbank.nus.edu.sg/handle/10635/121563
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
ChanCY.pdf5.8 MBAdobe PDF

OPEN

NoneView/Download

Page view(s)

108
checked on Oct 12, 2018

Download(s)

70
checked on Oct 12, 2018

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.